These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1902150)

  • 1. Management of acute myocardial infarction 1990: a perspective.
    Vogel JH
    Clin Cardiol; 1991 Jan; 14(1):5-9. PubMed ID: 1902150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of economic considerations on clinical decisionmaking: the case of thrombolytic therapy.
    Brody B; Wray N; Bame S; Ashton C; Petersen N; Harward M
    Med Care; 1991 Sep; 29(9):899-910. PubMed ID: 1921539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Care of acute myocardial infarction by noninvasive and invasive cardiologists: procedure use, cost and outcome.
    Di Salvo TT; Paul SD; Lloyd-Jones D; Smith AJ; Villarreal-Levy G; Bamezai V; Hussain SI; Eagle KA; O'Gara PT
    J Am Coll Cardiol; 1996 Feb; 27(2):262-9. PubMed ID: 8557892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Pilote L; Califf RM; Sapp S; Miller DP; Mark DB; Weaver WD; Gore JM; Armstrong PW; Ohman EM; Topol EJ
    N Engl J Med; 1995 Aug; 333(9):565-72. PubMed ID: 7623907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction.
    Kaul P; Armstrong PW; Cowper PA; Eisenstein EL; Granger CB; Van de Werf F; Mark DB
    Am Heart J; 2005 Apr; 149(4):637-44. PubMed ID: 15990746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction.
    de Boer MJ; van Hout BA; Liem AL; Suryapranata H; Hoorntje JC; Zijlstra F
    Am J Cardiol; 1995 Oct; 76(11):830-3. PubMed ID: 7572666
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost and quality of life: thrombolysis and primary angioplasty.
    Goldman L
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):38S-41S. PubMed ID: 7775713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost, uncertainty, and doctors' decisions. The case of thrombolytic therapy.
    Lessler DS; Avins AL
    Arch Intern Med; 1992 Aug; 152(8):1665-72. PubMed ID: 1497400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioplasty for the treatment of acute myocardial infarction.
    Beatt KJ; Fath-Ordoubadi F
    Heart; 1997 Oct; 78 Suppl 2(Suppl 2):12-5. PubMed ID: 9422964
    [No Abstract]   [Full Text] [Related]  

  • 10. The cost of an open infarct-related artery: comparison of treatment modalities in the reperfusion era.
    Aguirre FV
    Mayo Clin Proc; 1994 Jan; 69(1):87-9. PubMed ID: 8271856
    [No Abstract]   [Full Text] [Related]  

  • 11. Reperfusion in waiting: what queue should we join?
    Leung RC; Armstrong PW
    Am Heart J; 2002 Sep; 144(3):377-9. PubMed ID: 12228771
    [No Abstract]   [Full Text] [Related]  

  • 12. Projected cost-effectiveness of primary angioplasty for acute myocardial infarction.
    Lieu TA; Gurley RJ; Lundstrom RJ; Ray GT; Fireman BH; Weinstein MC; Parmley WW
    J Am Coll Cardiol; 1997 Dec; 30(7):1741-50. PubMed ID: 9385902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overutilization and underutilization of thrombolysis in routine clinical practice.
    Sleight P
    J Am Coll Cardiol; 2001 May; 37(6):1588-9. PubMed ID: 11345369
    [No Abstract]   [Full Text] [Related]  

  • 14. Survey of practicing cardiologists in Maryland on their choice of thrombolytic therapy for acute myocardial infarction.
    Plotnick GD; Ziskind AA; Vogel RA
    Am J Cardiol; 1992 Feb; 69(4):327-30. PubMed ID: 1734643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creation of the recombinant tissue plasminogen activator (rt-PA) image and its influence on practice habits.
    Sherry S; Marder VJ
    J Am Coll Cardiol; 1991 Nov; 18(6):1579-82. PubMed ID: 1939964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoption of thrombolytic therapy in the management of acute myocardial infarction.
    Hlatky MA; Cotugno H; O'Connor C; Mark DB; Pryor DB; Califf RM
    Am J Cardiol; 1988 Mar; 61(8):510-4. PubMed ID: 3125736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underuse of invasive procedures among Medicaid patients with acute myocardial infarction.
    Philbin EF; McCullough PA; DiSalvo TG; Dec GW; Jenkins PL; Weaver WD
    Am J Public Health; 2001 Jul; 91(7):1082-8. PubMed ID: 11441735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary coronary angioplasty versus thrombolysis for acute myocardial infarction.
    Fresco C
    Lancet; 2003 Apr; 361(9365):1303; author reply 1304-5. PubMed ID: 12699989
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction.
    Zeymer U; Schröder R; Machnig T; Neuhaus KL
    Am Heart J; 2003 Oct; 146(4):686-91. PubMed ID: 14564324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial.
    Pilote L; Granger C; Armstrong PW; Mark DB; Hlatky MA
    Med Care; 1995 Jun; 33(6):598-610. PubMed ID: 7760576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.